Nanjing University School of Medicine Clinical Trials
Sponsors / Nanjing University School of Medicine
According to ClinicalTrials.gov, Nanjing University School of Medicine has served as lead sponsor on 36 registered trials. Across the portfolio, 4 are in recruitment, 1 are active non-recruiting, and 19 have reached completion. 3 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Across the portfolio, planned enrollment totals 3,725 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
36
Total Trials
4
Recruiting
1
Other Active
19
Completed
3
Terminated / Withdrawn
3,725
Total Enrollment
Termination reasons: Recruitment67% ยท Business33%
Recent Terminations
- Solid Tumor"Portfolio prioritization"
- FSGS"The recruitment of subject is very difficult"
- IgA Nephropathy"low-rate of enrollment"
Active Trials (1 total)
- Lupus Nephritis (LN) PHASE2NCT07340463
- ANCA-associated Vasculitis PHASE1NCT06285279
- NCT06226896
- NCT06376214
- Light Chain Amyloidosis PHASE1NCT05978661